Cargando…
COVID-19 and related symptoms in patients under disulfiram for alcohol use disorder
Autores principales: | Tamburin, Stefano, Mantovani, Elisa, De Bernardis, Ernesto, Zipeto, Donato, Lugoboni, Fabio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7814518/ https://www.ncbi.nlm.nih.gov/pubmed/33464469 http://dx.doi.org/10.1007/s11739-021-02633-y |
Ejemplares similares
-
COVID-19-related symptom clustering in a primary care vs internal medicine setting
por: Lenti, Marco Vincenzo, et al.
Publicado: (2021) -
Adult attention-deficit/hyperactivity disorder symptoms, cognitive dysfunction and quality of life in high-dose use of benzodiazepine and Z-drug
por: Federico, Angela, et al.
Publicado: (2020) -
Telemedicine and the risk of overshadowing children with Kawasaki disease in a worldwide coronavirus pandemic climate
por: Rigante, Donato
Publicado: (2021) -
Non-invasive Brain Stimulation for Gambling Disorder: A Systematic Review
por: Zucchella, Chiara, et al.
Publicado: (2020) -
Atypical manifestations of COVID-19: to know signs and symptoms to recognize the whole disease in the Emergency Department
por: Pagliari, Danilo, et al.
Publicado: (2021)